Brief: Pulse Biosciences Enrolls First Patients in NANOPULSE-AF IDE Pivotal Clinical Study Evaluating nPulse™ Cardiac Catheter System for Atrial Fibrillation
07/04/2026 12:30
April 7 (Reuters) - Pulse Biosciences Inc PLSE.O: PULSE BIOSCIENCES ENROLLS FIRST PATIENTS IN NANOPULSE-AF IDE PIVOTAL CLINICAL STUDY EVALUATING NPULSE™ CARDIAC CATHETER SYSTEM FOR ATRIAL FIBRILLATION Source text: ID:nBw3KqMPma Further company coverage: PLSE.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pulse Biosciences
See all newsUS RESEARCH ROUNDUP-Affiliated Managers Group, Goldman Sachs, Vaxcyte
Pulse Biosciences Inc reports results for the quarter ended June 30 - Earnings Summary
Pulse Biosciences Q2 net loss widens, cash position strengthens
Pulse Biosciences Inc expected to post a loss of 36 cents a share - Earnings Preview
Brief: Pulse Biosciences, Inc. Announces Planned Redemption Of Warrants